{"title":"芦笋抗肿瘤双环六肽RA-VII的酪氨酸-3或酪氨酸-6氟化类似物的合成及细胞毒性评价","authors":"Yukio Hitotsuyanagi, Ken Morita, Tatsuro Anzai, Tomoyo Hasuda, Niro Inaba, Koichi Takeya","doi":"10.1016/j.phytol.2025.102967","DOIUrl":null,"url":null,"abstract":"<div><div>An RA-VII analogue with a fluorine atom introduced to the Tyr-3 ε position was synthesized from cycloisodityrosine, obtained through the chemical degradation of RA-VII, and fluorotetrapeptide. Additionally, an analogue with a fluorine atom at the Tyr-6 εa position was prepared via a substitution reaction involving the amino group of an amino-RA-VII derivative using a fluoride species. Compared with RA-VII, the Tyr-3 fluorinated analogue exhibited 300 times lower cytotoxicity toward the HL-60 cell line and 370 times lower cytotoxicity toward the HCT-116 cell line. In contrast, the Tyr-6 fluorinated analogue was 3.3 times and 1.1 times less cytotoxic toward these cell lines than RA-VII. These results indicate that substituting a fluorine atom for the aryl proton at the Tyr-3 ε position markedly reduces the cytotoxic activity. In contrast, the impact of such substitution at the Tyr-6 εa position is minimal.</div></div>","PeriodicalId":20408,"journal":{"name":"Phytochemistry Letters","volume":"67 ","pages":"Article 102967"},"PeriodicalIF":1.3000,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Synthesis and cytotoxicity evaluation of tyrosine-3 or tyrosine-6 fluorinated analogues of RA-VII, an antitumor bicyclic hexapeptide from Rubia cordifolia\",\"authors\":\"Yukio Hitotsuyanagi, Ken Morita, Tatsuro Anzai, Tomoyo Hasuda, Niro Inaba, Koichi Takeya\",\"doi\":\"10.1016/j.phytol.2025.102967\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>An RA-VII analogue with a fluorine atom introduced to the Tyr-3 ε position was synthesized from cycloisodityrosine, obtained through the chemical degradation of RA-VII, and fluorotetrapeptide. Additionally, an analogue with a fluorine atom at the Tyr-6 εa position was prepared via a substitution reaction involving the amino group of an amino-RA-VII derivative using a fluoride species. Compared with RA-VII, the Tyr-3 fluorinated analogue exhibited 300 times lower cytotoxicity toward the HL-60 cell line and 370 times lower cytotoxicity toward the HCT-116 cell line. In contrast, the Tyr-6 fluorinated analogue was 3.3 times and 1.1 times less cytotoxic toward these cell lines than RA-VII. These results indicate that substituting a fluorine atom for the aryl proton at the Tyr-3 ε position markedly reduces the cytotoxic activity. In contrast, the impact of such substitution at the Tyr-6 εa position is minimal.</div></div>\",\"PeriodicalId\":20408,\"journal\":{\"name\":\"Phytochemistry Letters\",\"volume\":\"67 \",\"pages\":\"Article 102967\"},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2025-05-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Phytochemistry Letters\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1874390025010560\",\"RegionNum\":4,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phytochemistry Letters","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1874390025010560","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
摘要
以RA-VII化学降解得到的环异二酪氨酸和氟四肽为原料,在tyr3 ε位置上引入氟原子,合成了RA-VII类似物。此外,通过用氟基团取代氨基- ra - vii衍生物的氨基,制备了在tyr6 εa位置上含有氟原子的类似物。与RA-VII相比,Tyr-3氟化类似物对HL-60细胞系的细胞毒性降低300倍,对HCT-116细胞系的细胞毒性降低370倍。相比之下,Tyr-6氟化类似物对这些细胞系的细胞毒性比RA-VII低3.3倍和1.1倍。这些结果表明,在tyr3 ε位置用氟原子取代芳基质子可显著降低细胞毒活性。相反,这种取代在tyr6 εa位置的影响是最小的。
Synthesis and cytotoxicity evaluation of tyrosine-3 or tyrosine-6 fluorinated analogues of RA-VII, an antitumor bicyclic hexapeptide from Rubia cordifolia
An RA-VII analogue with a fluorine atom introduced to the Tyr-3 ε position was synthesized from cycloisodityrosine, obtained through the chemical degradation of RA-VII, and fluorotetrapeptide. Additionally, an analogue with a fluorine atom at the Tyr-6 εa position was prepared via a substitution reaction involving the amino group of an amino-RA-VII derivative using a fluoride species. Compared with RA-VII, the Tyr-3 fluorinated analogue exhibited 300 times lower cytotoxicity toward the HL-60 cell line and 370 times lower cytotoxicity toward the HCT-116 cell line. In contrast, the Tyr-6 fluorinated analogue was 3.3 times and 1.1 times less cytotoxic toward these cell lines than RA-VII. These results indicate that substituting a fluorine atom for the aryl proton at the Tyr-3 ε position markedly reduces the cytotoxic activity. In contrast, the impact of such substitution at the Tyr-6 εa position is minimal.
期刊介绍:
Phytochemistry Letters invites rapid communications on all aspects of natural product research including:
• Structural elucidation of natural products
• Analytical evaluation of herbal medicines
• Clinical efficacy, safety and pharmacovigilance of herbal medicines
• Natural product biosynthesis
• Natural product synthesis and chemical modification
• Natural product metabolism
• Chemical ecology
• Biotechnology
• Bioassay-guided isolation
• Pharmacognosy
• Pharmacology of natural products
• Metabolomics
• Ethnobotany and traditional usage
• Genetics of natural products
Manuscripts that detail the isolation of just one new compound are not substantial enough to be sent out of review and are out of scope. Furthermore, where pharmacology has been performed on one new compound to increase the amount of novel data, the pharmacology must be substantial and/or related to the medicinal use of the producing organism.